To explore the anti-tumor role of Sev in glioma in vivo, we performed the xenograft experiments using LN229 cells stably transfected with HMMR-AS1 overexpression vector or pcDNA after exposure to 5.1% Sev or not. The gene discussed is HMMR; the disease is central nervous system cancer.